share_log

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target

HC Wainwright & Co.重申买入Actinium Pharma,维持50美元的目标股价
Benzinga ·  05/21 18:52

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price target.

HC Wainwright & Co. 分析师Joseph Pantginis重申买入Actinium Pharma(美交所:ATNM),维持50美元的目标价格。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发